BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iessi E, Logozzi M, Mizzoni D, Di Raimo R, Supuran CT, Fais S. Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy. Metabolites 2017;8:E2. [PMID: 29295495 DOI: 10.3390/metabo8010002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Menezes JC, Diederich M. Translational role of natural coumarins and their derivatives as anticancer agents. Future Med Chem 2019;11:1057-82. [PMID: 31140865 DOI: 10.4155/fmc-2018-0375] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
2 Safari Yazd H, Yang Y, Li L, Yang L, Li X, Pan X, Chen Z, Jiang J, Cui C, Tan W. Precise Deposition of Polydopamine on Cancer Cell Membrane as Artificial Receptor for Targeted Drug Delivery. iScience 2020;23:101750. [PMID: 33367224 DOI: 10.1016/j.isci.2020.101750] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Supuran CT. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2018;27:963-70. [PMID: 30426805 DOI: 10.1080/13543784.2018.1548608] [Cited by in Crossref: 99] [Cited by in F6Publishing: 98] [Article Influence: 24.8] [Reference Citation Analysis]
4 Angeli A, Carta F, Nocentini A, Winum JY, Zalubovskis R, Akdemir A, Onnis V, Eldehna WM, Capasso C, Simone G, Monti SM, Carradori S, Donald WA, Dedhar S, Supuran CT. Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment. Metabolites 2020;10:E412. [PMID: 33066524 DOI: 10.3390/metabo10100412] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
5 Nocentini A, Angeli A, Carta F, Winum JY, Zalubovskis R, Carradori S, Capasso C, Donald WA, Supuran CT. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021;36:561-80. [PMID: 33615947 DOI: 10.1080/14756366.2021.1882453] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
6 He R, Wang Z, Shi W, Yu L, Xia H, Huang Z, Liu S, Zhao X, Xu Y, Yam JWP, Cui Y. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value. Biomed Pharmacother 2021;138:111529. [PMID: 34311529 DOI: 10.1016/j.biopha.2021.111529] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Supuran CT. Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors. J Exp Pharmacol 2020;12:603-17. [PMID: 33364855 DOI: 10.2147/JEP.S265620] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
8 Kalinin S, Malkova A, Sharonova T, Sharoyko V, Bunev A, Supuran CT, Krasavin M. Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors. Int J Mol Sci 2021;22:13405. [PMID: 34948200 DOI: 10.3390/ijms222413405] [Reference Citation Analysis]
9 Ruzzolini J, Laurenzana A, Andreucci E, Peppicelli S, Bianchini F, Carta F, Supuran CT, Romanelli MN, Nediani C, Calorini L. A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer. J Enzyme Inhib Med Chem 2020;35:391-7. [PMID: 31865754 DOI: 10.1080/14756366.2019.1706090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
10 Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR. Targeting Tumor Microenvironment for Cancer Therapy. Int J Mol Sci 2019;20:E840. [PMID: 30781344 DOI: 10.3390/ijms20040840] [Cited by in Crossref: 267] [Cited by in F6Publishing: 254] [Article Influence: 89.0] [Reference Citation Analysis]
11 Nocentini A, Supuran CT. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018). Expert Opin Ther Pat 2018;28:729-40. [PMID: 30074415 DOI: 10.1080/13543776.2018.1508453] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 20.3] [Reference Citation Analysis]
12 Spugnini EP, Logozzi M, Di Raimo R, Mizzoni D, Fais S. A Role of Tumor-Released Exosomes in Paracrine Dissemination and Metastasis. Int J Mol Sci. 2018;19. [PMID: 30544664 DOI: 10.3390/ijms19123968] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
13 Halcrow PW, Geiger JD, Chen X. Overcoming Chemoresistance: Altering pH of Cellular Compartments by Chloroquine and Hydroxychloroquine. Front Cell Dev Biol 2021;9:627639. [PMID: 33634129 DOI: 10.3389/fcell.2021.627639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Comito G, Ippolito L, Chiarugi P, Cirri P. Nutritional Exchanges Within Tumor Microenvironment: Impact for Cancer Aggressiveness.Front Oncol. 2020;10:396. [PMID: 32266157 DOI: 10.3389/fonc.2020.00396] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
15 Iessi E, Vona R, Cittadini C, Matarrese P. Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path. Biomedicines 2021;9:1942. [PMID: 34944758 DOI: 10.3390/biomedicines9121942] [Reference Citation Analysis]
16 Li Y, Luo Y, Li X, Huang Z, Wang Y. Nanoparticles breakthroughs tumor treatment limitations by regulating tumor immune microenvironment to enhance tumor immunotherapy efficacy. Smart Materials in Medicine 2021;2:314-21. [DOI: 10.1016/j.smaim.2021.08.004] [Reference Citation Analysis]
17 Stefanucci A, Angeli A, Dimmito MP, Luisi G, Del Prete S, Capasso C, Donald WA, Mollica A, Supuran CT. Activation of β- and γ-carbonic anhydrases from pathogenic bacteria with tripeptides. J Enzyme Inhib Med Chem 2018;33:945-50. [PMID: 29747543 DOI: 10.1080/14756366.2018.1468530] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
18 Zhang H, Lu J, Liu J, Zhang G, Lu A. Advances in the discovery of exosome inhibitors in cancer. J Enzyme Inhib Med Chem 2020;35:1322-30. [PMID: 32543905 DOI: 10.1080/14756366.2020.1754814] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
19 Worsley CM, Veale RB, Mayne ES. The acidic tumour microenvironment: Manipulating the immune response to elicit escape. Hum Immunol 2022:S0198-8859(22)00030-1. [PMID: 35216847 DOI: 10.1016/j.humimm.2022.01.014] [Reference Citation Analysis]
20 Ünlü A, Duman-Özdamar ZE, Çaloğlu B, Binay B. Enzymes for Efficient CO2 Conversion. Protein J 2021;40:489-503. [PMID: 34100161 DOI: 10.1007/s10930-021-10007-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Menezes JC, Diederich MF. Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology. European Journal of Medicinal Chemistry 2019;182:111637. [DOI: 10.1016/j.ejmech.2019.111637] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
22 Fliegel L. Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer. Rev Physiol Biochem Pharmacol 2020. [PMID: 32776252 DOI: 10.1007/112_2020_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Gnocchi D, Castellaneta F, Cesari G, Fiore G, Sabbà C, Mazzocca A. Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy. J Pharm Pharmacol 2021:rgab070. [PMID: 34014301 DOI: 10.1093/jpp/rgab070] [Reference Citation Analysis]
24 Xu Q, Jia X, Wu Q, Shi L, Ma Z, Ba N, Zhao H, Xia X, Zhang Z. Esomeprazole affects the proliferation, metastasis, apoptosis and chemosensitivity of gastric cancer cells by regulating lncRNA/circRNA-miRNA-mRNA ceRNA networks. Oncol Lett 2020;20:329. [PMID: 33101498 DOI: 10.3892/ol.2020.12193] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Tozzi M, Sørensen CE, Magni L, Christensen NM, Bouazzi R, Buch CM, Stefanini M, Duranti C, Arcangeli A, Novak I. Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreatic Cancer and Stellate Cells. Cancers (Basel) 2020;12:E640. [PMID: 32164284 DOI: 10.3390/cancers12030640] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
26 Logozzi M, Capasso C, Di Raimo R, Del Prete S, Mizzoni D, Falchi M, Supuran CT, Fais S. Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity. J Enzyme Inhib Med Chem 2019;34:272-8. [PMID: 30734594 DOI: 10.1080/14756366.2018.1538980] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
27 Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018;28:709-12. [PMID: 30217119 DOI: 10.1080/13543776.2018.1523897] [Cited by in Crossref: 60] [Cited by in F6Publishing: 73] [Article Influence: 15.0] [Reference Citation Analysis]
28 Logozzi M, Mizzoni D, Capasso C, Del Prete S, Di Raimo R, Falchi M, Angelini DF, Sciarra A, Maggi M, Supuran CT, Fais S. Plasmatic exosomes from prostate cancer patients show increased carbonic anhydrase IX expression and activity and low pH. J Enzyme Inhib Med Chem 2020;35:280-8. [PMID: 31790614 DOI: 10.1080/14756366.2019.1697249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
29 Supuran CT. Carbonic Anhydrases and Metabolism. Metabolites 2018;8:E25. [PMID: 29561812 DOI: 10.3390/metabo8020025] [Cited by in Crossref: 75] [Cited by in F6Publishing: 89] [Article Influence: 18.8] [Reference Citation Analysis]
30 Logozzi M, Mizzoni D, Angelini DF, Di Raimo R, Falchi M, Battistini L, Fais S. Microenvironmental pH and Exosome Levels Interplay in Human Cancer Cell Lines of Different Histotypes. Cancers (Basel) 2018;10:E370. [PMID: 30301144 DOI: 10.3390/cancers10100370] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 17.0] [Reference Citation Analysis]
31 Spugnini EP, Fais S. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors. Expert Opin Ther Pat 2020;30:15-25. [PMID: 31847622 DOI: 10.1080/13543776.2020.1704733] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
32 Gillies RJ, Pilot C, Marunaka Y, Fais S. Targeting acidity in cancer and diabetes. Biochim Biophys Acta Rev Cancer. 2019;1871:273-280. [PMID: 30708040 DOI: 10.1016/j.bbcan.2019.01.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
33 Ihraiz WG, Ahram M, Bardaweel SK. Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells. Acta Pharm 2020;70:179-90. [PMID: 31955147 DOI: 10.2478/acph-2020-0020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
34 Matboli M, ElGwad AA, Hasanin AH, El-Tawdi A, Habib EK, Elmansy RA, Ibrahim D, Shehata H, Tash F. Pantoprazole attenuates tumorigenesis via inhibition of exosomal secretion in a rat model of hepatic precancerous lesion induced by diethylnitrosamine and 2-acetamidofluorene. J Cell Biochem 2019;120:14946-59. [PMID: 31009125 DOI: 10.1002/jcb.28757] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Fernandes C, Suares D, Yergeri MC. Tumor Microenvironment Targeted Nanotherapy. Front Pharmacol 2018;9:1230. [PMID: 30429787 DOI: 10.3389/fphar.2018.01230] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
36 Supuran CT. An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opinion on Drug Metabolism & Toxicology 2020;16:297-307. [DOI: 10.1080/17425255.2020.1743679] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
37 Logozzi M, Spugnini E, Mizzoni D, Di Raimo R, Fais S. Extracellular acidity and increased exosome release as key phenotypes of malignant tumors. Cancer Metastasis Rev 2019;38:93-101. [PMID: 30715644 DOI: 10.1007/s10555-019-09783-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
38 Thacker PS, Shaikh P, Angeli A, Arifuddin M, Supuran CT. Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2019;34:1172-7. [PMID: 31218888 DOI: 10.1080/14756366.2019.1626376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
39 Raskov H, Orhan A, Gaggar S, Gögenur I. Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy. Front Oncol 2021;11:668731. [PMID: 34094963 DOI: 10.3389/fonc.2021.668731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Hálfdánarson ÓÖ, Fall K, Ogmundsdottir MH, Lund SH, Steingrímsson E, Ogmundsdottir HM, Zoega H. Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population‐based case‐control study. Pharmacoepidemiol Drug Saf 2019;28:471-8. [DOI: 10.1002/pds.4702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
41 Berrino E, Supuran CT. Novel approaches for designing drugs that interfere with pH regulation. Expert Opin Drug Discov 2019;14:231-48. [PMID: 30681011 DOI: 10.1080/17460441.2019.1567488] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]